David W Hall

10PUBLICATIONS
43CO-AUTHORS
Cancer geneticsPredictive and prognostic markersSpeciation and extinctionEpigenetics (incl. genome methylation and epigenomics)Plant and fungus systematics and taxonomy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 31, 2026
Costs and benefits of whole-exome, whole-transcriptome sequencing versus 50-gene panels for genomic profiling in solid tumors.

Jesse D Ortendahl, Gebra Cuyun Carter, Eliza M Zantema

|Jun 17, 2025
Costs and Benefits of Whole-Exome, Whole-Transcriptome Sequencing in Patients With Advanced Non-Small Cell Lung Cancer.

Jesse D Ortendahl, Gebra Cuyun Carter, Snehal G Thakkar

|Jan 26, 2025
Circulating Tumor DNA as a Marker of Recurrence Risk in Stage III Colorectal Cancer: The α-CORRECT Study.

Brenda Diergaarde, Greg Young, David W Hall

|Jun 17, 2024
Associations with other cancer-related biomarkers might contribute to poor outcomes in RAS-altered, younger patients with colorectal cancer.

Madappa N Kundranda, Ariane C Kemkes, Mark C Evans

|Mar 11, 2024
Value of next generation sequencing (NGS) testing in advanced cancer patients.

Jesse D Ortendahl, Gebra Cuyun Carter, Snehal G Thakkar

|Jul 18, 2023
Spontaneous single-nucleotide substitutions and microsatellite mutations have distinct distributions of fitness effects.

Yevgeniy Plavskin, Maria Stella de Biase, Naomi Ziv

Pageof 2

Frequent Collaborators

3 joint publications

Jesse D Ortendahl

3 joint publications

Gebra Cuyun Carter

2 joint publications

Yara Abdou

2 joint publications

Katalin Bognar